Podcast


Presenter: G. Michael Allan MD CCFP James McCormack BSc (Pharm) Pharm D Michael Kolber BSc MD CCFP MSc

Podcast: BS Medicine Episode #532: Topical Anal Fissure Treatments – getting to the bottom of it
0:00

In episode 532, Mike and James bring Mike Kolber in to chat about potential treatments for anal fissures. We discuss the evidence for topical nitroglycerin, topical calcium channel blockers and topical Vitamin E. At the end we provide guidance that will blow your head off – or maybe we were all using too high a…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

BS Medicine Episode #610: Vitamin D and Mortality – Don’t bet your life on it!

In episode 610, Jamie and James chat with Jennifer Young about yet another Vitamin D Tools for Practice. We look at what happens to mortality, CVD and cancer when Vitamin…
Listen 0.5 credits available

Pharmascope Épisode 115: Ostéoporose: solidifier la prise en charge – partie 3

Un nouvel épisode du Pharmascope est maintenant disponible! Dans de ce 115ème épisode, Sébastien, Nicolas et Isabelle terminent leur série d’épisodes sur l’ostéoporose. Dans cette troisième et dernière partie, on…
Listen 0.5 credits available

Pharmascope Épisode 114: Ostéoporose: solidifier la prise en charge – partie 2

Un premier épisode du Pharmascope enregistré devant public est maintenant disponible! En direct de Jonquière, Sébastien, Nicolas et Isabelle continuent leur série d’épisodes sur l’ostéoporose. Dans cette deuxième partie, on…
Listen 0.5 credits available

Presenter(s):

G. Michael Allan MD CCFP James McCormack BSc (Pharm) Pharm D Michael Kolber BSc MD CCFP MSc

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • G. Michael Allan MD CCFP
  • James McCormack BSc (Pharm) Pharm D
  • Michael Kolber BSc MD CCFP MSc

Spearkers do not have any conflicts of interest to declare.